101 related articles for article (PubMed ID: 16081931)
1. Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.
Lin S; Arcangel P; Medina-Selby A; Coit D; Ng P; Nguyen S; McCoin C; Gyenes A; Hu C; Tandeske L; Phelps B; Chien D
J Clin Microbiol; 2005 Aug; 43(8):3917-24. PubMed ID: 16081931
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to a novel antigen in acute hepatitis C virus infections.
Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
[TBL] [Abstract][Full Text] [Related]
3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
4. Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.
Chien DY; Arcangel P; Medina-Selby A; Coit D; Baumeister M; Nguyen S; George-Nascimento C; Gyenes A; Kuo G; Valenzuela P
J Clin Microbiol; 1999 May; 37(5):1393-7. PubMed ID: 10203493
[TBL] [Abstract][Full Text] [Related]
5. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
[TBL] [Abstract][Full Text] [Related]
7. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.
Attallah AM; Ismail H; Tabll AA; Shiha GE; El-Dosoky I
J Immunoassay Immunochem; 2003; 24(4):395-407. PubMed ID: 14677657
[TBL] [Abstract][Full Text] [Related]
8. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
9. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
10. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
[TBL] [Abstract][Full Text] [Related]
14. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
15. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
[TBL] [Abstract][Full Text] [Related]
17. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
19. Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity.
Mihailova M; Fiedler M; Boos M; Petrovskis I; Sominskaya I; Roggendorf M; Viazov S; Pumpens P
Protein Expr Purif; 2006 Nov; 50(1):43-8. PubMed ID: 16889980
[TBL] [Abstract][Full Text] [Related]
20. Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters.
Salminen T; Juntunen E; Khanna N; Pettersson K; Talha SM
J Virol Methods; 2016 Feb; 228():67-73. PubMed ID: 26615808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]